{"id":"https://openalex.org/W4401619103","doi":"https://doi.org/10.1158/1078-0432.26711160","title":"Supplementary Table S3 from Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma","display_name":"Supplementary Table S3 from Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma","publication_year":2024,"publication_date":"2024-08-15","ids":{"openalex":"https://openalex.org/W4401619103","doi":"https://doi.org/10.1158/1078-0432.26711160"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.26711160","doi":"https://doi.org/10.1158/1078-0432.26711160","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.26711160","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.26711160","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021866663","display_name":"Jennifer Jess","orcid":"https://orcid.org/0009-0002-6266-2133","observed_orcids":["https://orcid.org/0009-0002-6266-2133"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Jess","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-6266-2133","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056579626","display_name":"Katie M. Sorensen","orcid":"https://orcid.org/0009-0002-9711-3150","observed_orcids":["https://orcid.org/0009-0002-9711-3150"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katie M. Sorensen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-9711-3150","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033838605","display_name":"Elissa A. Boguslawski","orcid":"https://orcid.org/0000-0003-4233-903X","observed_orcids":["https://orcid.org/0000-0003-4233-903X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elissa A. Boguslawski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4233-903X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007906801","display_name":"Matthew C. Stout","orcid":"https://orcid.org/0009-0004-6232-4198","observed_orcids":["https://orcid.org/0009-0004-6232-4198"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew C. Stout","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-6232-4198","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026553060","display_name":"Zachary Madaj","orcid":"https://orcid.org/0000-0003-2330-0500","observed_orcids":["https://orcid.org/0000-0003-2330-0500"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary B. Madaj","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2330-0500","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094200232","display_name":"Benjamin P. Caiello","orcid":"https://orcid.org/0000-0003-4277-2909","observed_orcids":["https://orcid.org/0000-0003-4277-2909"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin P. Caiello","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4277-2909","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055633447","display_name":"Monica M. Pomaville","orcid":"https://orcid.org/0009-0008-0498-5544","observed_orcids":["https://orcid.org/0009-0008-0498-5544"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monica Pomaville","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-0498-5544","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102784065","display_name":"Elizabeth R. Wilson","orcid":"https://orcid.org/0009-0009-7013-856X","observed_orcids":["https://orcid.org/0009-0009-7013-856X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth R. Wilson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0009-7013-856X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029155666","display_name":"Seneca S. Kinn-Gurzo","orcid":"https://orcid.org/0009-0004-0407-9788","observed_orcids":["https://orcid.org/0009-0004-0407-9788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seneca S. Kinn-Gurzo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-0407-9788","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101912481","display_name":"Curtis C. Parker","orcid":"https://orcid.org/0000-0002-8481-5949","observed_orcids":["https://orcid.org/0000-0002-8481-5949"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Curtis C. Parker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8481-5949","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033278652","display_name":"Sridhar Madan Veluvolu","orcid":"https://orcid.org/0009-0003-2655-5506","observed_orcids":["https://orcid.org/0009-0003-2655-5506"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sridhar M. Veluvolu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-2655-5506","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076793661","display_name":"Taylor V. Brysgel","orcid":"https://orcid.org/0000-0002-4791-6492","observed_orcids":["https://orcid.org/0000-0002-4791-6492"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taylor V. Brysgel","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4791-6492","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024251842","display_name":"Rebecca Kaufman","orcid":"https://orcid.org/0000-0001-8535-9730","observed_orcids":["https://orcid.org/0000-0001-8535-9730"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Kaufman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8535-9730","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065580138","display_name":"Susan M. Kitchen-Goosen","orcid":"https://orcid.org/0000-0001-9291-056X","observed_orcids":["https://orcid.org/0000-0001-9291-056X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan M. Kitchen-Goosen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9291-056X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044743630","display_name":"Jenna Marie Gedminas","orcid":"https://orcid.org/0000-0001-8140-6835","observed_orcids":["https://orcid.org/0000-0001-8140-6835"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenna M. Gedminas","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8140-6835","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5028721392","display_name":"Patrick Joseph Grohar","orcid":"https://orcid.org/0000-0002-1071-4563","observed_orcids":["https://orcid.org/0000-0002-1071-4563"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patrick J. Grohar","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1071-4563","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.40869998931884766,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.40869998931884766,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.3831000030040741,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.05290000140666962,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ewing-sarcoma","display_name":"Ewing sarcoma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/atr-inhibition","display_name":"ATR inhibition","score":0.9900000095367432},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8529999852180481},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6029999852180481},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.34700000286102295}],"concepts":[{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8218652009963989},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.749066948890686},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.6920228004455566},{"id":"https://openalex.org/C2778256501","wikidata":"https://www.wikidata.org/wiki/Q223911","display_name":"Sarcoma","level":2,"score":0.5978610515594482},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4758698344230652},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4165623188018799},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2661888599395752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.260724276304245},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.2594144940376282},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23164919018745422},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16693216562271118},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.062177181243896484},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.059505850076675415},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.26711160","doi":"https://doi.org/10.1158/1078-0432.26711160","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.26711160","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.26711160.v1","doi":"https://doi.org/10.1158/1078-0432.26711160.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.26711160.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Cell_Context_Is_the_Third_Axis_of_Synergy_for_the_Combination_of_ATR_Inhibition_and_Cisplatin_in_Ewing_Sarcoma/26711160/1/files/48553845.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/26711160","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Cell_Context_Is_the_Third_Axis_of_Synergy_for_the_Combination_of_ATR_Inhibition_and_Cisplatin_in_Ewing_Sarcoma/26711160","pdf_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Cell_Context_Is_the_Third_Axis_of_Synergy_for_the_Combination_of_ATR_Inhibition_and_Cisplatin_in_Ewing_Sarcoma/26711160","source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.26711160","doi":"https://doi.org/10.1158/1078-0432.26711160","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.26711160","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4401619103.pdf","grobid_xml":"https://content.openalex.org/works/W4401619103.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4401619150","https://openalex.org/W4392987151","https://openalex.org/W4399529221","https://openalex.org/W4366990191","https://openalex.org/W2886397600","https://openalex.org/W6888831175","https://openalex.org/W3114373975","https://openalex.org/W7054927887","https://openalex.org/W6901886701","https://openalex.org/W6958375134"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-08-16T00:00:00"}